ArticlePharmaceutics2022

Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy.

Kandasamy Saravanakumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.